Mowery, Cody T.
Freimer, Jacob W. http://orcid.org/0000-0001-9239-2272
Chen, Zeyu
CasanÃ-Galdón, Salvador http://orcid.org/0000-0001-8714-3001
Umhoefer, Jennifer M.
Arce, Maya M. http://orcid.org/0000-0003-4234-9908
Gjoni, Ketrin
Daniel, Bence http://orcid.org/0000-0002-2410-8767
Sandor, Katalin http://orcid.org/0000-0003-2892-4865
Gowen, Benjamin G.
Nguyen, Vinh
Simeonov, Dimitre R.
Garrido, Christian M.
Curie, Gemma L.
Schmidt, Ralf http://orcid.org/0000-0002-6697-0363
Steinhart, Zachary
Satpathy, Ansuman T. http://orcid.org/0000-0002-5167-537X
Pollard, Katherine S.
Corn, Jacob E. http://orcid.org/0000-0002-7798-5309
Bernstein, Bradley E.
Ye, Chun Jimmie http://orcid.org/0000-0001-6560-3783
Marson, Alexander http://orcid.org/0000-0002-2734-5776
Article History
Received: 20 December 2022
Accepted: 4 April 2024
First Online: 29 May 2024
Competing interests
: C.T.M. is a Bio+Health Venture Fellow at Andreessen Horowitz. J.W.F. was a consultant for NewLimit, is a current employee of Genentech and has equity in Roche. B.D. is a current employee of Genentech. K.S. is a current employee of Cartography Biosciences. B.G.G. is a current employee of Spotlight Therapeutics. A.T.S. is a founder of Immunai and Cartography Biosciences and receives research funding from Allogene Therapeutics and Merck Research Laboratories. J.E.C. is a co-founder of Spotlight Therapeutics and Serac Biosciences, and a member of the scientific advisory boards of Spotlight Therapeutics, Serac Biosciences, Mission Therapeutics, Relation Therapeutics, Hornet Bio, Kano Therapeutics, and the Joint AstraZeneca-CRUK Functional Genomics Centre. The lab of J.E.C. has funded collaborations with Allogene, Cimeio and Serac. B.E.B. declares outside interests in Fulcrum Therapeutics, HiFiBio, Arsenal Biosciences, Design Pharmaceuticals, Cell Signaling Technologies and Chroma Medicine. C.J.Y. is a founder of and holds equity in Dropprint Genomics (now Immunai) and Survey Genomics, is a scientific advisory board member for and holds equity in Related Sciences and Immunai, is a consultant for and holds equity in Maze Therapeutics and is a consultant for TReX Bio, HiBio, ImYoo and Santa Ana. C.J.Y. is an innovation investigator for the Arc Institute. C.J.Y. has received research support from the Chan Zuckerberg Initiative, Chan Zuckerberg Biohub, Genentech, BioLegend, ScaleBio and Illumina. A.M. is a cofounder of Site Tx, Arsenal Biosciences, Spotlight Therapeutics and Survey Genomics, serves on the boards of directors at Site Tx, Spotlight Therapeutics and Survey Genomics, is a member of the scientific advisory boards of Site Tx, Arsenal Biosciences, Spotlight Therapeutics, Survey Genomics, NewLimit, Amgen, and Tenaya, owns stock in Arsenal Biosciences, Site Tx, Spotlight Therapeutics, NewLimit, Survey Genomics, Tenaya and Lightcast, and has received fees from Site Tx, Arsenal Biosciences, Spotlight Therapeutics, NewLimit, 23andMe, PACT Pharma, Juno Therapeutics, Tenaya, Lightcast, Trizell, Vertex, Merck, Amgen, Genentech, GLG, ClearView Healthcare, AlphaSights, Rupert Case Management, Bernstein and ALDA. A.M. is an investor in and informal advisor to Offline Ventures and a client of EPIQ. The Marson laboratory has received research support from the Parker Institute for Cancer Immunotherapy, the Emerson Collective, Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead and Anthem and reagents from Genscript and Illumina. The remaining authors declare no competing interests.